NOX1 and inflammatory bowel disease: VEO-IBD patients expressing catalytically inactive, full-length NOX1 presented with pancolitis, Paneth cell metaplasia, cryptitis, and crypt abscess formation; their serum LPS levels or microbiota composition were not reported [8].